Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Sunday.

Several other equities analysts have also recently weighed in on PAHC. Barclays raised their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Up 1.1 %

Phibro Animal Health stock opened at $20.27 on Friday. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The company has a fifty day simple moving average of $22.71 and a 200 day simple moving average of $21.15. The company has a market cap of $821.00 million, a P/E ratio of 47.14, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53.

Institutional Trading of Phibro Animal Health

Several institutional investors and hedge funds have recently bought and sold shares of PAHC. nVerses Capital LLC acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health in the third quarter valued at $70,000. China Universal Asset Management Co. Ltd. raised its position in shares of Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the period. CWM LLC lifted its stake in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after buying an additional 4,175 shares during the last quarter. Finally, Algert Global LLC acquired a new stake in shares of Phibro Animal Health during the 2nd quarter worth about $193,000. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.